Invesco
ELDN icon

Invesco’s Eledon Pharmaceuticals ELDN Stock Holding History

Invesco’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.4K Sell
30,968
-701
-2% -$1.65K ﹤0.01% 3631
2025
Q4 		$47.8K Sell
31,669
-222
-0.7% -$528 ﹤0.01% 3710
2025
Q3 		$82.6K Buy
31,891
+2,151
+7% +$6.29K ﹤0.01% 3707
2025
Q2 		$80.6K Buy
+29,740
New +$89.2K ﹤0.01% 3676
2015
Q3 		– Sell
-2
Closed -$5K – 3846
2015
Q2 		$5K Buy
+2
New +$3.87K ﹤0.01% 4195

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Invesco's ELDN Position: Q1 2026 in Review

Invesco reduced its Eledon Pharmaceuticals (ELDN) stake by 2.2% in Q1 2026, selling an estimated $1.65K and leaving 30,968 shares worth $95.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3631.

Invesco first reported a position in ELDN in Q2 2015 and has held it in 5 quarters since. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Invesco held 30,968 shares of Eledon Pharmaceuticals worth $95.4K as of Q1 2026.
  • Invesco sold 701 Eledon Pharmaceuticals shares in Q1 2026, an estimated $1.65K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3631 holding.
  • Invesco first reported a position in Eledon Pharmaceuticals in Q2 2015 and has held it in 5 quarters since.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.